KURA position history
The shares of Kura Oncology (KURA) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 100,829 shares, $1.9M, 0.50% of portfolio
- 2021 Q4: 110,829 shares, $1.6M, 0.39% of portfolio, Add +9.9%
- 2022 Q1: 113,329 shares, $1.8M, 0.47% of portfolio, Add +2.3%
- 2022 Q2: 117,829 shares, $2.2M, 0.59% of portfolio, Add +4.0%
- 2022 Q3: 206,329 shares, $2.8M, 0.76% of portfolio, Add +75.1%
- 2022 Q4: 144,784 shares, $1.8M, 0.51% of portfolio, Reduce −29.8%
- 2023 Q1: 109,784 shares, $1.3M, 0.40% of portfolio, Reduce −24.2%
- 2023 Q2: 357,784 shares, $3.8M, 1.0% of portfolio, Add +225.9%
- 2023 Q3: 550,784 shares, $5M, 1.6% of portfolio, Add +53.9%
- 2023 Q4: 492,684 shares, $7.1M, 1.7% of portfolio, Reduce −10.5%
- 2024 Q1: 412,663 shares, $8.8M, 2.0% of portfolio, Reduce −16.2%
- 2024 Q2: 423,500 shares, $8.7M, 2.1% of portfolio, Add +2.6%
- 2024 Q3: 408,368 shares, $8M, 1.9% of portfolio, Reduce −3.6%
- 2024 Q4: 448,368 shares, $3.9M, 0.99% of portfolio, Add +9.8%
- 2025 Q1: 463,368 shares, $3.1M, 0.87% of portfolio, Add +3.3%
- 2025 Q2: 463,368 shares, $2.7M, 0.74% of portfolio
- 2025 Q3: 463,368 shares, $4.1M, 1.0% of portfolio
- 2025 Q4: 235,868 shares, $2.5M, 0.57% of portfolio, Reduce −49.1%
- 2026 Q1: 235,868 shares, $1.9M, 0.44% of portfolio
- 2026 Q2: 120,568 shares, $1.3M, 0.25% of portfolio, Reduce −48.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|